Buliga-Finis, O.N.; Ouatu, A.; Tanase, D.M.; Badescu, M.C.; Dima, N.; Gosav, E.M.; Popescu, D.; Rezus, C.
The Role of Galectin-3 as a Biomarker in the Cardio–Renal–Metabolic Pathology Axis. J. Clin. Med. 2025, 14, 6071.
https://doi.org/10.3390/jcm14176071
AMA Style
Buliga-Finis ON, Ouatu A, Tanase DM, Badescu MC, Dima N, Gosav EM, Popescu D, Rezus C.
The Role of Galectin-3 as a Biomarker in the Cardio–Renal–Metabolic Pathology Axis. Journal of Clinical Medicine. 2025; 14(17):6071.
https://doi.org/10.3390/jcm14176071
Chicago/Turabian Style
Buliga-Finis, Oana Nicoleta, Anca Ouatu, Daniela Maria Tanase, Minerva Codruta Badescu, Nicoleta Dima, Evelina Maria Gosav, Diana Popescu, and Ciprian Rezus.
2025. "The Role of Galectin-3 as a Biomarker in the Cardio–Renal–Metabolic Pathology Axis" Journal of Clinical Medicine 14, no. 17: 6071.
https://doi.org/10.3390/jcm14176071
APA Style
Buliga-Finis, O. N., Ouatu, A., Tanase, D. M., Badescu, M. C., Dima, N., Gosav, E. M., Popescu, D., & Rezus, C.
(2025). The Role of Galectin-3 as a Biomarker in the Cardio–Renal–Metabolic Pathology Axis. Journal of Clinical Medicine, 14(17), 6071.
https://doi.org/10.3390/jcm14176071
